Trials / Completed
CompletedNCT06983925
A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal Women
A Randomized, Open-label, Single-dose, Two-crossover Bioavailability Study of Single Oral Administration of GS1-144 Tablets Under Fasting Condition in Healthy Postmenopausal Female Subjects in China
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetic (PK) characteristics of GS1-144 tablets and the relative bioavailability of the two preparations in healthy postmenopausal female subjects in China.
Detailed description
To evaluate the pharmacokinetic (PK) characteristics of GS1-144 tablets and the relative bioavailability of the two preparations in healthy postmenopausal female subjects in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GS1-144 Tablet with new preparation (T) | GS1-144 Tablet with new preparation (T) |
| DRUG | GS1-144 Tablet with present preparation (R) | A single oral dose of GS1-144 Tablet with present preparation |
Timeline
- Start date
- 2025-04-30
- Primary completion
- 2025-07-14
- Completion
- 2025-07-14
- First posted
- 2025-05-21
- Last updated
- 2025-08-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06983925. Inclusion in this directory is not an endorsement.